rs1554041295
Variant summary
Our verdict is Pathogenic. The variant received 14 ACMG points: 14P and 0B. PVS1_StrongPM2PP5_Very_Strong
The NM_020928.2(ZSWIM6):c.2737C>T(p.Arg913*) variant causes a stop gained change involving the alteration of a non-conserved nucleotide. The variant was absent in control chromosomes in GnomAD project. In-silico tool predicts a pathogenic outcome for this variant. Variant has been reported in ClinVar as Likely pathogenic (★★).
Frequency
Consequence
NM_020928.2 stop_gained
Scores
Clinical Significance
Conservation
Publications
- acromelic frontonasal dysostosisInheritance: AD Classification: STRONG, SUPPORTIVE Submitted by: Orphanet, PanelApp Australia, Labcorp Genetics (formerly Invitae), G2P
- neurodevelopmental disorder with movement abnormalities, abnormal gait, and autistic featuresInheritance: AD Classification: STRONG Submitted by: Labcorp Genetics (formerly Invitae)
Genome browser will be placed here
ACMG classification
Our verdict: Pathogenic. The variant received 14 ACMG points.
Transcripts
RefSeq
Ensembl
Frequencies
GnomAD3 genomes Cov.: 32
GnomAD4 exome Data not reliable, filtered out with message: AC0 AF: 0.00 AC: 0AN: 1398236Hom.: 0 Cov.: 31 AF XY: 0.00 AC XY: 0AN XY: 689590
GnomAD4 genome Cov.: 32
ClinVar
Submissions by phenotype
Neurodevelopmental disorder with movement abnormalities, abnormal gait, and autistic features Pathogenic:5
- -
- -
- -
- -
The variant is not observed in the gnomAD v2.1.1 dataset. Predicted Consequence/Location: Stop-gained (nonsense): predicted to result in a loss or disruption of normal protein function through protein truncation. The predicted truncated protein may be shortened by more than 10%. The variant has been previously reported as de novo in a similarly affected individual (PMID: 29198722). The variant has been reported at least twice as pathogenic with clinical assertions and evidence for the classification (ClinVar ID: VCV000431797 /PMID: 29198722). Therefore, this variant is classified as Pathogenic according to the recommendation of ACMG/AMP guideline. -
not provided Pathogenic:4
This sequence change creates a premature translational stop signal (p.Arg913*) in the ZSWIM6 gene. It is expected to result in an absent or disrupted protein product. For these reasons, this variant has been classified as Pathogenic. The current clinical and genetic evidence is not sufficient to establish whether loss-of-function variants in ZSWIM6 cause disease. This variant has been observed to be likely or confirmed de novo in multiple individuals affected with severe-profound intellectual disability/developmental delay and additional neurological features, but without frontonasal or limb malformations (PMID: 29198722, Invitae). ClinVar contains an entry for this variant (Variation ID: 431797). This variant is not present in population databases (ExAC no frequency). Experimental studies have shown that this nonsense change does not trigger nonsense-mediated decay of the ZSWIM6 mRNA. This suggests a truncated ZSWIM6 protein lacking the Sin3-like domain exists, which may have a dominant-negative effect. (PMID: 29198722). -
Published functional studies demonstrate a dominant-negative effect on the protein (Palmer et al., 2017); Not observed in large population cohorts (gnomAD); Nonsense variant predicted to result in protein truncation as the last 303 amino acids are lost; This variant is associated with the following publications: (PMID: 29198722, 33958584, 34758253) -
- -
The ZWIM6 c.2737C>T; p.Arg913Ter variant (rs1554041295, ClinVar Variation ID: 431797), is a recurrent pathogenic variant reported in the literature in at least eight unrelated affected individuals and has been primarily observed to occur de novo (Palmer 2017, Yanagishita 2021). This variant is absent from the Genome Aggregation Database (v2.1.1), indicating it is not a common polymorphism. This variant induces an early termination codon in the penultimate exon of the ZSWIM6 gene. Transcriptional assays suggest this does not lead to nonsense mediated decay but is predicted to result in a truncated ZSWIM6 protein (Palmer 2017). Based on available information, this variant is considered to be pathogenic. References: Palmer EE et al. A Recurrent De Novo Nonsense Variant in ZSWIM6 Results in Severe Intellectual Disability without Frontonasal or Limb Malformations. Am J Hum Genet. 2017 Dec 7;101(6):995-1005. PMID: 29198722. Yanagishita T et al. A recurrent de novo ZSWIM6 variant in a Japanese patient with severe neurodevelopmental delay and frequent vomiting. Hum Genome Var. 2021 May 6;8(1):16. PMID: 33958584. -
ZSWIM6 related intellectual disability Pathogenic:1
De novo. Recurrent in 7 individuals with overlapping neurocognitive phenotype. Gene expressed in brain and role in neurodevelopment and function. -
ZSWIM6-related disorder Pathogenic:1
The ZSWIM6 c.2737C>T variant is predicted to result in premature protein termination (p.Arg913*). This variant has been reported as a recurrent de novo variant in multiple patients with syndromic intellectual disability (see for example - Palmer et al. 2017. PubMed ID: 29198722). This variant has not been reported in a large population database (http://gnomad.broadinstitute.org), indicating this variant is rare. This variant is located in the penultimate exon and functional studies found it does not undergo nonsense mediated decay and may act in a dominant-negative manner (Palmer et al. 2017. PubMed ID: 29198722). This variant is interpreted as pathogenic. -
Computational scores
Source:
Splicing
Find out detailed SpliceAI scores and Pangolin per-transcript scores at